Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
暂无分享,去创建一个
Andrew C. Wood | Daniel Martinez | Sharon J. Diskin | John M. Maris | Sunkyu Kim | Yimei Li | Erica L. Carpenter | K. Cole | G. Caponigro | J. Maris | S. Diskin | E. Attiyeh | A. Wood | E. Carpenter | B. Pawel | S. Parasuraman | Yimei Li | D. Martinez | Robert W Schnepp | Lori S. Hart | Kristina A. Cole | Edward F. Attiyeh | Bruce Pawel | JulieAnn Rader | Mike R. Russell | Michael S. Nakazawa | Lili T. Belcastro | Sudha Parasuraman | Giordano Caponigro | Robert W. Schnepp | J. Rader | Sunkyu Kim | R. Schnepp | L. Belcastro | M. R. Russell
[1] Huaqing Zhao,et al. Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma , 2011, Science Translational Medicine.
[2] Marc A. Attiyeh,et al. Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy. , 2008, Genome research.
[3] J. Sage,et al. Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.
[4] J. Harbour,et al. Rb function in cell-cycle regulation and apoptosis , 2000, Nature Cell Biology.
[5] M. Barbacid,et al. Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.
[6] Giovanni Parmigiani,et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.
[7] J. Easton,et al. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. , 1998, Cancer research.
[8] Cynthia Winter,et al. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma , 2011, Proceedings of the National Academy of Sciences.
[9] K. Cole,et al. New Strategies in Refractory and Recurrent Neuroblastoma: Translational Opportunities to Impact Patient Outcome , 2012, Clinical Cancer Research.
[10] Robert L. Sutherland,et al. Cyclin D as a therapeutic target in cancer , 2011, Nature Reviews Cancer.
[11] I. Wierstra,et al. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4 , 2006, Biological chemistry.
[12] J. Maris,et al. Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Harbour,et al. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.
[14] Steven J. M. Jones,et al. The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.
[15] D. Zwijnenburg,et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.
[16] J. Harper,et al. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. , 1997, Molecular biology of the cell.
[17] K. Cole,et al. Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma , 2007, Clinical Cancer Research.
[18] John M. Maris,et al. Identification of ALK as a major familial neuroblastoma predisposition gene , 2008, Nature.
[19] Jean Y. J. Wang,et al. Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.
[20] Jinghui Zhang,et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. , 2012, JAMA.
[21] Adam A. Margolin,et al. High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma , 2005, Genes, chromosomes & cancer.
[22] S. Gygi,et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. , 2011, Cancer cell.
[23] G. Peters,et al. CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms , 2007, Molecular and Cellular Biology.
[24] K. Cole,et al. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression , 2007, Genes, chromosomes & cancer.
[25] Bill Bynum,et al. Lancet , 2015, The Lancet.
[26] N. Raje,et al. Cyclin dependent kinases in cancer , 2012, Cancer biology & therapy.
[27] E. Knudsen,et al. Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition , 2012, The Journal of Biological Chemistry.
[28] Jan Koster,et al. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. , 2008, Cancer research.
[29] J. Maris. Recent advances in neuroblastoma. , 2010, The New England journal of medicine.
[30] K. Cole,et al. Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma. , 2013, Cancer research.
[31] M. Kitagawa,et al. The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2. , 1996, The EMBO journal.
[32] Marc A. Attiyeh,et al. Erratum: Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy (Genome Research (2009) 19 (276-283)) , 2009 .
[33] D. Gisselsson,et al. Copy number defects of G1‐Cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis , 2012, Genes, chromosomes & cancer.
[34] Rogier Versteeg,et al. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma , 2003, Genes, chromosomes & cancer.
[35] Michael Ruogu Zhang,et al. Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence , 2022 .
[36] Y. Mossé,et al. Targeting ALK in neuroblastoma—preclinical and clinical advancements , 2012, Nature Reviews Clinical Oncology.
[37] J. Khan,et al. Altered expression of cell cycle genes distinguishes aggressive neuroblastoma , 2005, Oncogene.
[38] A. Tyner,et al. FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors. , 2011, Cancer research.